Posted in | News

Nanosolar Meets DOE Grant Qualifications to Develop PV Systems for Commercial Buildings

Nanosolar, which produces thin-film solar cells and panels using nanoparticle inks and CIGS, has met or exceeded all 10 key tasks in conclusion of a U.S. Department of Energy grant worth $42 million for a Solar America Initiative (SAI) Technology Pathway Partnership (TPP) program.

In 2006, Nanosolar had received the grant to design large-scale photovoltaic systems that deliver an unprecedented price per watt performance for use in commercial buildings. The company got sign off from the U.S. Department of Energy in April 2012.

The TPP project began in September 2007 and involved four partners, including Nanosolar. The objective of the project was to develop solar electric systems for flat commercial rooftops to provide grid-parity along with other alternative energy sources. Nanosolar provided advanced cell and module technology, while Conergy contributed inverter technology and systems optimization and Sunlink offered mounting technology. The pilot installation was done by Suntechnics.

The SAI team aimed at utilizing Nanosolar's advanced scalable photovoltaic cell technology in large-scale installations on commercial buildings to provide grid-parity photovoltaic systems by developing an integrated portfolio of designs and system components based on advancements in mounting, inverter and module technologies.

During the project, Nanosolar achieved cell power conversion efficiency of over 13% on the production floor that has 115 MW of nameplate annual capacity. The company installed 3.4 MW of solar panels for two pilot deployments, a 2.88 MW installation situated in Oregon and a 550 kW installation for Camp Perry located in Ohio. Moreover, the company has created, sold, and installed at 14 sites across the world.

According to third-party estimations, Nanosolar will achieve grid parity economics in 2015 as indicated by DOE program objectives. The company keeps on collecting consistency and performance data provided by third-party testing laboratories. Independent engineering institutions and firms analyzes this data.

Source: http://www.nanosolar.com

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). Nanosolar Meets DOE Grant Qualifications to Develop PV Systems for Commercial Buildings. AZoBuild. Retrieved on April 23, 2024 from https://www.azobuild.com/news.aspx?newsID=15245.

  • MLA

    Scanlon, Joel. "Nanosolar Meets DOE Grant Qualifications to Develop PV Systems for Commercial Buildings". AZoBuild. 23 April 2024. <https://www.azobuild.com/news.aspx?newsID=15245>.

  • Chicago

    Scanlon, Joel. "Nanosolar Meets DOE Grant Qualifications to Develop PV Systems for Commercial Buildings". AZoBuild. https://www.azobuild.com/news.aspx?newsID=15245. (accessed April 23, 2024).

  • Harvard

    Scanlon, Joel. 2019. Nanosolar Meets DOE Grant Qualifications to Develop PV Systems for Commercial Buildings. AZoBuild, viewed 23 April 2024, https://www.azobuild.com/news.aspx?newsID=15245.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.